Gac. Vanhaasteren et al., DIFFERENT EFFECTS OF CONTINUOUS-INFUSION OF INTERLEUKIN-1 AND INTERLEUKIN-6 ON THE HYPOTHALAMIC-HYPOPHYSEAL-THYROID AXIS, Endocrinology, 135(4), 1994, pp. 1336-1345
The cytokines interleukin-1 (IL-1) and IL-6 are thought to be importan
t mediators in the suppression of thyroid function during nonthyroidal
illness. In this study we compared the effects of IL-1 and IL-6 infus
ion on the hypothalamus-pituitary-thyroid axis in rats. Cytokines were
administered by continuous ip infusion of 4 mu g IL-1 alpha/day for 1
, 2, or 7 days or of 15 mu g IL-6/day for 7 days. Body weight and temp
erature, food and water intake, and plasma TSH, T-4, free T-4 (FT4), T
-3, and corticosterone levels were measured daily, and hypothalamic pr
o-TRH messenger RNA (mRNA) and hypophysial TSH beta mRNA were determin
ed after termination of the experiments. Compared with saline-treated
controls, infusion of IL-1, but not of IL-6, produced a transient decr
ease in food and water intake, a transient increase in body temperatur
e, and a prolonged decrease in body weight. Both cytokines caused tran
sient decreases in plasma TSH and T-4, which were greater and more pro
longed with IL-1 than with IL-6, whereas they effected similar transie
nt increases in the plasma FT4 fraction. Infusion with IL-1, but not I
L-6, also induced transient decreases in plasma FT4 and T-3 and a tran
sient increase in plasma corticosterone. Hypothalamic pro-TRH mRNA was
significantly decreased (-73%) after 7 days, but not after 1 or 2 day
s, of IL-1 infusion and was unaffected by IL-6 infusion. Hypophysial T
SH beta mRNA was significantly decreased after 2 (-62%) and 7 (-62%) d
ays, but not after 1 day, of IL-1 infusion and was unaffected by IL-6
infusion. These results are in agreement with previous findings that I
L-1, more so than IL-6, directly inhibits thyroid hormone production.
They also indicate that IL-1 and IL-6 both decrease plasma T-4 binding
. Furthermore, both cytokines induce an acute and dramatic decrease in
plasma TSH before (IL-1) or even without (IL-6) a decrease in hypotha
lamic pro-TRH mRNA or hypophysial TSH beta mRNA, suggesting that the a
cute decrease in TSH secretion is not caused by decreased pro-TRH and
TSH beta gene expression. The TSH-suppressive effect of IL-6, either a
dministered as such or induced by IL-1 infusion, may be due to a direc
t effect on the thyrotroph, whereas additional effects of IL-1 may inv
olve changes in the hypothalamic release of somatostatin or TRH. As gl
ucucorticoids are known to suppress hypothalamic TRH mRNA levels, it i
s speculated that the decrease in pro-TRH gene expression caused by pr
olonged infusion of IL-1 is mediated by the high plasma corticosterone
levels.